ACE2 and viral infectious disease: For example, the higher expression level of the angiotensin-converting-enzyme-2 (ACE2) and lower level of pro-inflammatory cytokines (i.e., interleukin-6) in women after viral infections could explain their higher susceptibility to developing post-COVID otologic symptoms (16, 17).